STAGE IIIB LUNG CANCER AJCC V8
Clinical trials for STAGE IIIB LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for seniors with lung cancer: ACHIEVE trial tests best treatment combo
Disease control Recruiting nowThis study tests whether adding chemotherapy to immunotherapy works better than immunotherapy alone for adults aged 70 and older with advanced non-small cell lung cancer. About 304 participants will receive either pembrolizumab alone or pembrolizumab plus chemotherapy. The goal i…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
Lung cancer trial: is pre- and Post-Surgery therapy better than Post-Surgery alone?
Disease control Recruiting nowThis study compares two standard approaches for people with stage II-IIIB non-small cell lung cancer that can be removed with surgery. One group gets chemotherapy and immunotherapy both before and after surgery (perioperative), while the other gets it only after surgery (adjuvant…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Could a drug after surgery keep lung cancer from coming back?
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug durvalumab after surgery can help prevent early-stage non-small cell lung cancer from returning. About 306 people who have had their lung cancer completely removed will either receive durvalumab or be closely watched without …
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Immunotherapy boost after lung cancer surgery shows promise in major trial
Disease control Recruiting nowThis study looks at whether adding the immunotherapy drug pembrolizumab to standard chemotherapy after lung cancer surgery can help people live longer without the cancer coming back. About 1,210 adults with stage II to IIIB non-small cell lung cancer that was removed by surgery w…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New combo therapy aims to extend life in aggressive lung cancer
Disease control Recruiting nowThis study tests whether adding bevacizumab to the standard drug osimertinib helps people with advanced EGFR-mutant non-small cell lung cancer live longer without their cancer growing. About 300 adults with stage IIIB or IV disease will receive either the combination or osimertin…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Yoga may ease cancer treatment side effects for patients and families
Symptom relief Recruiting nowThis study tests whether a special yoga program can improve physical function, fatigue, sleep, and quality of life for people with lung or esophageal cancer who are getting radiation therapy, and also for their family caregivers. About 400 patient-caregiver pairs will take part. …
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 01, 2026 15:28 UTC
-
Smart radiation planning may cut lung cancer treatment side effects
Symptom relief Recruiting nowThis study looks at whether updating radiation treatment plans at set times during therapy can lower side effects for people with non-small cell lung cancer. As tumors shrink from radiation, healthy tissue can get exposed, so researchers want to see if planned re-designs help. Ab…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated May 01, 2026 15:24 UTC
-
Simple breathing workouts before lung surgery may cut pneumonia risk
Symptom relief Recruiting nowThis study tests whether doing special breathing exercises for several weeks before lung cancer surgery can lower the chance of serious lung problems like pneumonia or breathing failure after the operation. About 220 adults with stage I to IIIB lung cancer will either do the brea…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Apr 29, 2026 15:02 UTC
-
Can personalized chemoradiation protect lung cancer Patients' hearts?
Knowledge-focused Recruiting nowThis study looks at how chemoradiation for locally advanced lung cancer affects the heart. Researchers will track heart injury and fitness in 100 patients, using each person's risk profile to tailor treatment and potentially lower heart complications. The goal is to learn how to …
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:01 UTC